{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:28:32Z","timestamp":1793978912238,"version":"4.8.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019725","name":"Prince Sattam bin Abdulaziz University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["PSAU\/2025\/03\/37440"],"award-info":[{"award-number":["PSAU\/2025\/03\/37440"]}],"id":[{"id":"10.13039\/100019725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119262","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:19:25Z","timestamp":1787325565000},"page":"119262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Purine-centred fused, conformationally constrained, and ring-expanded analogues in antitumor and antiviral drug discovery: A comprehensive review"],"prefix":"10.1016","volume":"319","author":[{"given":"Manisha","family":"Nidhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prawez","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Hamed","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ibrahim","family":"Foudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq Mohammed","family":"Aljarba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcot","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akil","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Sadique","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejmech.2026.119262_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25092050","article-title":"Recent advances in the chemical synthesis and evaluation of anticancer nucleoside analogues","volume":"25","author":"Guinan","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119262_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108990","article-title":"Thiopurines analogues with additional ring: synthesis, spectroscopic properties, and anticancer potency","volume":"24","author":"Krancewicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119262_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020174","article-title":"Antiviral potential of azathioprine and its derivative 6- mercaptopurine: a narrative literature review","volume":"17","author":"Rios-Usuga","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119262_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19","volume":"6","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2026.119262_bib5","article-title":"StatPearls publishing copyright \u00a9 2025, StatPearls publishing LLC.: treasure island (FL) with ineligible companies","author":"Fernandez","year":"2025","journal-title":"DisClosure: Ahmed Munir declares no relevant financial relationships with ineligible companies"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119262_bib6","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.3390\/cimb45080433","article-title":"Recent advances in molecular mechanisms of nucleoside antivirals","volume":"45","author":"Kamzeeva","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"25","key":"10.1016\/j.ejmech.2026.119262_bib7","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1021\/jm000326i","article-title":"Synthesis and antitumor activity of thieno-separated tricyclic purines","volume":"43","author":"Seley","year":"2000","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2026.119262_bib8","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1021\/jm00045a025","article-title":"Tricyclic analogues of acyclovir and ganciclovir. Influence of substituents in the heterocyclic moiety on the antiviral activity","volume":"37","author":"Golankiewicz","year":"1994","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2026.119262_bib9","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1021\/jm010922s","article-title":"Fluorescent tricyclic analogues of acyclovir and ganciclovir. A structure-antiviral activity study","volume":"44","author":"Golankiewicz","year":"2001","journal-title":"J. Med. Chem."},{"issue":"5\u20138","key":"10.1016\/j.ejmech.2026.119262_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1081\/NCN-120022684","article-title":"Synthesis and fluorescent properties of 6-(4-biphenylyl)-3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine analogues of acyclovir and ganciclovir","volume":"22","author":"Goslinski","year":"2003","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119262_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s13318-021-00716-x","article-title":"Advances in thiopurine drug delivery: the current state-of-the-art","volume":"46","author":"Bayoumy","year":"2021","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119262_bib12","doi-asserted-by":"crossref","first-page":"15165","DOI":"10.1021\/acs.jmedchem.2c01010","article-title":"6-Thioguanosine monophosphate prodrugs display enhanced performance against thiopurine-resistant leukemia and breast cancer cells","volume":"65","author":"Moreno","year":"2022","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119262_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ddtec.2005.08.012","article-title":"Locked nucleic acid (LNA): high affinity targeting of RNA for diagnostics and therapeutics","volume":"2","author":"Kauppinen","year":"2005","journal-title":"Drug Discov. Today Technol."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119262_bib14","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/j.bmc.2005.12.060","article-title":"The purines: potent and versatile small molecule inhibitors and modulators of key biological targets","volume":"14","author":"Legraverend","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2016.02.018","article-title":"Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors","volume":"112","author":"Sharma","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib16","article-title":"An insight into the rational design of recent purine-based scaffolds in targeting various cancer pathways","volume":"1274","author":"Chaurasiya","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119262_bib17","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1039\/D0MD00227E","article-title":"Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold","volume":"11","author":"Baillache","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib18","first-page":"356","article-title":"Pyrazolo[3,4\u2010d]pyrimidine scaffold: a review on synthetic approaches and EGFR and VEGFR inhibitory activities","author":"Kassab","year":"2022","journal-title":"Arch. Pharmazie"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119262_bib19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/med.21465","article-title":"Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides","volume":"37","author":"Perl\u00edkov\u00e1","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119262_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","article-title":"The evolution of nucleoside analogue antivirals: a review for chemists and non-chemists. Part 1: early structural modifications to the nucleoside scaffold","volume":"154","author":"Seley-Radtke","year":"2018","journal-title":"Antivir. Res."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119262_bib21","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1021\/jo5001687","article-title":"Copper-catalyzed intramolecular cyclization of N-propargyl-adenine: synthesis of purine-fused tricyclics","volume":"79","author":"Li","year":"2014","journal-title":"J. Org. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119262_bib22","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.drudis.2017.07.013","article-title":"Polypharmacology of conformationally locked methanocarba nucleosides","volume":"22","author":"Jacobson","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"14","key":"10.1016\/j.ejmech.2026.119262_bib23","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1021\/ja710342q","article-title":"Design, synthesis, and properties of 2\u2018,4\u2018-BNANC: a bridged nucleic acid analogue","volume":"130","author":"Abdur Rahman","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119262_bib24","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41467-018-03927-0","article-title":"Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity","volume":"9","author":"Cromwell","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119262_bib25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2174\/092986708784049612","article-title":"Current developments in the synthesis and biological activity of aza-C-nucleosides: immucillins and related compounds","volume":"15","author":"Merino","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119262_bib26","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1039\/D1MD00167A","article-title":"Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets","volume":"12","author":"Jacobson","year":"2021","journal-title":"RSC Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119262_bib27","doi-asserted-by":"crossref","first-page":"21264","DOI":"10.1021\/acs.jmedchem.4c02174","article-title":"Potent and selective human 5-HT(2B) serotonin receptor antagonists: 4'-cyano-(N)-methanocarba-adenosines by synthetic serendipity","volume":"67","author":"Tosh","year":"2024","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119262_bib28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1538-7836.2006.01866.x","article-title":"(N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets","volume":"4","author":"Bourdon","year":"2006","journal-title":"J. Thromb. Haemostasis"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119262_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bcp.2015.07.007","article-title":"Metabolic mapping of A3 adenosine receptor agonist MRS5980","volume":"97","author":"Fang","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119262_bib30","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1021\/jm020827z","article-title":"Synthesis and biological activity of strongly fluorescent tricyclic analogues of acyclovir and ganciclovir","volume":"45","author":"Goslinski","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejmech.2014.12.026","article-title":"Bioactive fused heterocycles: nucleoside analogs with an additional ring","volume":"97","author":"Jahnz-Wechmann","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119262_bib32","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.bmcl.2005.11.048","article-title":"Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR","volume":"16","author":"Richardson","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119262_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fchem.2016.00019","article-title":"Base-Modified nucleosides: Etheno derivatives","volume":"4","author":"Jahnz-Wechmann","year":"2016","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/reactions5040058","article-title":"Efficient synthesis of novel Triazolo[5,1-b]purines by Diacetoxyiodobenzene-Mediated oxidative cyclization of schiff bases","volume":"5","author":"Neymash","year":"2024","journal-title":"Reactions"},{"key":"10.1016\/j.ejmech.2026.119262_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2019.01.027","article-title":"1,2,4-Triazolo[1,5-a]pyrimidines in drug design","volume":"165","author":"Oukoloff","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119262_bib36","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1039\/D4RA08271K","article-title":"Recent advances in the synthesis, reaction, and bio-evaluation potential of purines as precursor pharmacophores in chemical reactions: a review","volume":"15","author":"Ragab","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119262_bib37","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s10593-014-1542-z","article-title":"8-Alkyl[1,2,4]Triazolo[5,1-b]Purines","volume":"50","author":"Savateev","year":"2014","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.ejmech.2026.119262_bib38","article-title":"Recent advances in the synthesis of xanthines: a short review","author":"Kapri","year":"2022","journal-title":"Sci. Tech. Rep."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119262_bib39","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1021\/jm011093d","article-title":"Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists","volume":"45","author":"M\u00fcller","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118384","article-title":"Novel tricycle expanded purine nucleosides with pan-viral activity","volume":"130","author":"Martin-Ghoteimi","year":"2025","journal-title":"Bioorg. Med. Chem."},{"issue":"40","key":"10.1016\/j.ejmech.2026.119262_bib41","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1021\/acs.orglett.4c03056","article-title":"Palladium-catalyzed bicycloaromatization of o-(Alkynyl)styrenes with alkynes: economical access to chrysene derivatives","volume":"26","author":"Liu","year":"2024","journal-title":"Org. Lett."},{"issue":"74","key":"10.1016\/j.ejmech.2026.119262_bib42","doi-asserted-by":"crossref","first-page":"9310","DOI":"10.1039\/c2cc33511e","article-title":"Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system","volume":"48","author":"D'Errico","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.119262_bib43","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3390\/biom10121627","article-title":"Biochemical pathways leading to the formation of wyosine derivatives in tRNA of archaea","volume":"10","author":"Urbonavi\u010dius","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119262_bib44","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.3390\/molecules27154996","article-title":"Design, synthesis and biological evaluation of [1,2,4]Triazolo[1,5-a]pyrimidine indole derivatives against gastric cancer cells MGC-803 via the suppression of ERK signaling pathway","volume":"27","author":"Yu","year":"2022","journal-title":"Molecules"},{"issue":"28","key":"10.1016\/j.ejmech.2026.119262_bib45","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1039\/c3cc37265k","article-title":"2,3-Dicyclohexylsuccinimide as a directing\/protecting group for the regioselective glycosylation or alkylation of purines","volume":"49","author":"Pal","year":"2013","journal-title":"Chem. Commun."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119262_bib46","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1039\/D2RA02063G","article-title":"Ultrasound-assisted transition-metal-free catalysis: a sustainable route towards the synthesis of bioactive heterocycles","volume":"12","author":"Borah","year":"2022","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119262_bib47","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ejmech.2008.04.012","article-title":"Design, synthesis and characterization of N9\/N7-substituted 6-aminopurines as VEGF-R and EGF-R inhibitors","volume":"44","author":"Peifer","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131239","article-title":"Novel acrylonitrile derived imidazo[4,5-b]pyridines as antioxidants and potent antiproliferative agents for pancreatic adenocarcinoma","volume":"266","author":"Bo\u010dek Pavlinac","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119262_bib49","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1021\/jm049580r","article-title":"(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists","volume":"48","author":"Tchilibon","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib50","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1021\/ol703041y","article-title":"Synthesis of bicyclo[3.1.0]hexane derivatives as conformationally restricted analogues of beta-arabinofuranosyl and alpha-galactofuranosyl rings","volume":"10","author":"Li","year":"2008","journal-title":"Org. Lett."},{"issue":"24","key":"10.1016\/j.ejmech.2026.119262_bib51","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1021\/ol000238s","article-title":"A remarkably simple chemicoenzymatic approach to structurally complex bicyclo[3.1.0]hexane carbocyclic nucleosides","volume":"2","author":"Moon","year":"2000","journal-title":"Org. Lett."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119262_bib52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1021\/ol006999c","article-title":"Synthesis using ring closure metathesis and effect on nucleoside transport of a (N)-methanocarba S-(4-nitrobenzyl)thioinosine derivative","volume":"3","author":"Lee","year":"2001","journal-title":"Org. Lett."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119262_bib53","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1039\/D3QO01112G","article-title":"Atom-economical synthesis of bicyclo[3.1.0]hexane silanes by gold-catalyzed Si\u2013H bond insertion reaction of 1,6-enynes with hydrosilanes","volume":"10","author":"Wang","year":"2023","journal-title":"Org. Chem. Front."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119262_bib54","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1021\/jo020249u","article-title":"Enantioselective synthesis of bicyclo[3.1.0]hexane carbocyclic nucleosides via a lipase-catalyzed asymmetric acetylation. Characterization of an unusual acetal byproduct","volume":"67","author":"Yoshimura","year":"2002","journal-title":"J. Org. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119262_bib55","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1038\/srep09139","article-title":"Amide-controlled, one-pot synthesis of tri-substituted purines generates structural diversity and analogues with trypanocidal activity","volume":"5","author":"Pineda de las Infantas y Villatoro","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119262_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40508-015-0029-2","article-title":"Heck and sonogashira couplings in aqueous media \u2013 application to unprotected nucleosides and nucleotides","volume":"3","author":"Herv\u00e9","year":"2015","journal-title":"Sustain. Chem. Process."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119262_bib57","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1021\/ol8020176","article-title":"The first synthesis of a novel 5:7:5-fused diimidazodiazepine ring system and some of its chemical properties","volume":"10","author":"Kumar","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.119262_bib58","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1080\/15257779408012169","article-title":"Nucleosides and nucleotides. 130. The synthesis of Imidazo[4, 5-e][1, 4] diazepine nucleosides from N -Substituted inosines. Nucleosides nucleotides & nucleic acids","volume":"13","author":"Aoyagi","year":"1994","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ejmech.2026.119262_bib59","doi-asserted-by":"crossref","first-page":"13385","DOI":"10.3390\/molecules181113385","article-title":"The novel [4,5-e][1,3]Diazepine-4,8-dione and acyclic carbamoyl imino-ureido derivatives of imidazole: synthesis, anti-viral and anti-tumor activity evaluations","volume":"18","author":"Wittine","year":"2013","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119262_bib60","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1021\/bi00355a025","article-title":"Transition-state stabilization by adenosine deaminase: structural studies of its inhibitory complex with deoxycoformycin","volume":"25","author":"Frick","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.119262_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113342","article-title":"Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: design, synthesis, antiproliferative activity and DNA\/RNA binding study","volume":"217","author":"Lon\u010dar","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"30","key":"10.1016\/j.ejmech.2026.119262_bib62","doi-asserted-by":"crossref","first-page":"29901","DOI":"10.18632\/oncotarget.4898","article-title":"NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3","volume":"6","author":"Xie","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119262_bib63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/ml100281b","article-title":"Novel, broad spectrum anticancer agents containing the tricyclic 5:7:5-Fused diimidazodiazepine ring system","volume":"2","author":"Kondaskar","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119262_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/molecules28010034","article-title":"Biological activity of amidino-substituted imidazo [4,5-b]pyridines","volume":"28","author":"Pavlinac","year":"2023","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.ejmech.2026.119262_bib65","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.3390\/molecules28207208","article-title":"Synthesis and antiproliferative activity of 2,6-Disubstituted Imidazo[4,5-b]pyridines prepared by suzuki cross coupling","volume":"28","author":"Bo\u010dek Pavlinac","year":"2023","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119262_bib66","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/ml300074j","article-title":"Discovery of disubstituted Imidazo[4,5-b]pyridines and purines as potent TrkA inhibitors","volume":"3","author":"Wang","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119262_bib67","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.bmc.2005.01.004","article-title":"Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues","volume":"13","author":"Ostrowski","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119262_bib68","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.ejmech.2009.03.005","article-title":"Synthesis and anti-VZV activity of 6-heteroaryl derivatives of tricyclic acyclovir and 9-{[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl}guanine analogues","volume":"44","author":"Ostrowski","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119262_bib69","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1016\/j.ejmech.2009.04.003","article-title":"Synthesis, antiviral activity, and stability of nucleoside analogs containing tricyclic bases","volume":"44","author":"Amblard","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119262_bib70","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/jm9905965","article-title":"Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists","volume":"43","author":"Jacobson","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300633","article-title":"Design, synthesis, antitumor activity and NMR\u2010Based metabolomics of novel amino substituted tetracyclic Imidazo[4,5\u2010b]Pyridine derivatives","volume":"19","author":"Perin","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119262_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106032","article-title":"Imidazo[4,5-b]pyridine derived tubulin polymerization inhibitors: design, synthesis, biological activity in vitro and computational analysis","volume":"127","author":"Bo\u010dek","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119262_bib73","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1016\/j.bmc.2018.09.031","article-title":"Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5-b]pyridine derivatives as potent and selective TAM inhibitors","volume":"26","author":"Baladi","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119262_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28114278","article-title":"Antitumor activity of s-Triazine derivatives: a systematic review","volume":"28","author":"Dai","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119262_bib75","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.3390\/molecules28207208","article-title":"Synthesis and antiproliferative activity of 2,6-Disubstituted Imidazo[4,5-b]pyridines prepared by suzuki cross coupling","volume":"28","author":"Bo\u010dek Pavlinac","year":"2023","journal-title":"Molecules"},{"issue":"27","key":"10.1016\/j.ejmech.2026.119262_bib76","doi-asserted-by":"crossref","first-page":"21604","DOI":"10.1039\/D5RA02893K","article-title":"From molecule to medicine: introducing emerging strategies to synthesize potent anticancer purine scaffolds","volume":"15","author":"Hashmi","year":"2025","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119262_bib77","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.leukres.2013.07.034","article-title":"Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies","volume":"37","author":"Sampath","year":"2013","journal-title":"Leuk. Res."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119262_bib78","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1016\/j.bmc.2012.03.004","article-title":"Synthesis and biological evaluation of a series of thieno-expanded tricyclic purine 2'-deoxy nucleoside analogues","volume":"20","author":"Wauchope","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib79","article-title":"Involvement of DNA damage response pathways in hepatocellular carcinoma","volume":"2014","author":"Yang","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejmech.2026.119262_bib80","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3390\/molecules29071556","article-title":"1,2,3-Triazole hybrids containing isatins and phenolic moieties: regioselective synthesis and molecular docking studies","volume":"29","author":"Maiuolo","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119262_bib81","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s40203-023-00157-1","article-title":"In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies","volume":"11","author":"Kumar","year":"2023","journal-title":"Silico Pharmacol"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119262_bib82","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1039\/D5MD00572H","article-title":"Recent advances in triazole hybrid molecules for the therapeutic management of neglected tropical diseases","volume":"16","author":"Malik","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119262_bib108","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1016\/j.bmc.2006.07.036","article-title":"Tricyclic etheno analogs of PMEG and PMEDAP: synthesis and biological activity","volume":"14","author":"Horejs\u00ed","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119262_bib83","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/14728214.2011.591786","article-title":"Emerging drugs for varicella-zoster virus infections","volume":"16","author":"Andrei","year":"2011","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119262_bib84","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jac\/dkm376","article-title":"Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus","volume":"60","author":"McGuigan","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119262_bib85","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0960-894X(00)00672-7","article-title":"Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of terminal unsaturation in the side chain","volume":"11","author":"Srinivasan","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119262_bib86","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkf037","article-title":"Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication","volume":"50","author":"Balzarini","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119262_bib87","doi-asserted-by":"crossref","first-page":"78","DOI":"10.32607\/actanaturae.11479","article-title":"Evaluation of the antiviral potential of modified heterocyclic base and 5\u2019-Norcarbocyclic nucleoside analogs against SARS-CoV-2","volume":"13","author":"Matyugina","year":"2021","journal-title":"Acta Nat."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119262_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043361","article-title":"Nucleoside analogs that inhibit SARS-CoV-2 replication by blocking interaction of virus polymerase with RNA","volume":"24","author":"Matyugina","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119262_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23102654","article-title":"Novel 5'-Norcarbocyclic derivatives of bicyclic Pyrrolo- and Furano[2,3-d]Pyrimidine nucleosides","volume":"23","author":"Klimenko","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119262_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119262_bib91","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1021\/acsinfecdis.5c00517","article-title":"Dual-site inhibition of SARS-CoV-2 RNA-dependent RNA polymerase by small molecules able to block viral replication identified through a computer-aided drug discovery approach","volume":"11","author":"Malune","year":"2025","journal-title":"ACS Infect. Dis."},{"issue":"7819","key":"10.1016\/j.ejmech.2026.119262_bib92","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119262_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118243","article-title":"Exploration of 4'-fluoro fleximer nucleoside analogues as potential broad-spectrum antiviral agents","volume":"128","author":"Davis","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib94","article-title":"Exploration of 4\u2032-fluoro fleximer nucleoside analogues as potential broad-spectrum antiviral agents","volume":"128","author":"Smith","year":"2025","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119262_bib95","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11030-021-10215-5","article-title":"In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase","volume":"26","author":"Celik","year":"2022","journal-title":"Mol. Divers."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119262_bib96","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acs.jmedchem.7b00734","article-title":"The ProTide prodrug technology: from the concept to the clinic","volume":"61","author":"Mehellou","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103260","article-title":"Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: design, multicomponent synthesis and antiproliferative activities","volume":"92","author":"Yang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115741","article-title":"Nucleoside-based anticancer drugs: mechanism of action and drug resistance","volume":"215","author":"Hruba","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119262_bib98","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(02)00788-X","article-title":"Nucleoside analogues and nucleobases in cancer treatment","volume":"3","author":"Galmarini","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2026.119262_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118642","article-title":"Rational design of dual PB2\/JAK2 inhibitors achieving balanced antiviral and host-directed immunomodulatory effects","volume":"307","author":"Yang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/molecules26040923","article-title":"Drug Discovery of Nucleos(t)ide Antiviral Agents: dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday","volume":"26","author":"Li","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119262_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2013.07.034","article-title":"Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies","volume":"37","author":"Sampath","year":"2013","journal-title":"Leuk. Res."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119262_bib102","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acs.jmedchem.7b00734","article-title":"The ProTide prodrug technology: from the concept to the clinic","volume":"61","author":"Mehellou","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119262_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115937","article-title":"Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS\/MS and its application in the clinical determination in patients with tumors associated with overactive bladder","volume":"240","author":"Lou","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119262_bib104","article-title":"Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejmech.2026.119262_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2022.1013285","article-title":"Artificial intelligence for antiviral drug discovery in low resourced settings: a perspective","volume":"2","author":"Namba-Nzanguim","year":"2022","journal-title":"Front. Drug Des. Discov."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119262_bib106","article-title":"Late-stage (radio)fluorination of alkyl phosphonates via electrophilic activation","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"25","key":"10.1016\/j.ejmech.2026.119262_bib107","doi-asserted-by":"crossref","first-page":"17517","DOI":"10.1021\/jacs.4c05854","article-title":"\"AquaF\" building blocks for water-compatible S(N)2 (18)F-Fluorination of small-molecule radiotracers","volume":"146","author":"Mou","year":"2024","journal-title":"J. Am. Chem. Soc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:07:12Z","timestamp":1793977632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":109,"alternative-id":["S0223523426007075"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119262","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purine-centred fused, conformationally constrained, and ring-expanded analogues in antitumor and antiviral drug discovery: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119262"}}